Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment with Statin on Atheroma Regression Evaluated by Intravascular Ultrasound with Virtual Histology [TRUTH] Study)

American Journal of Cardiology

Volumn 111, Issue 7, 2013, Pages 923-929

  Nozue, Tsuyoshi ^a   Yamamoto, Shingo ^b   Tohyama, Shinichi ^c   Fukui, Kazuki ^d   Umezawa, Shigeo ^e   Onishi, Yuko ^e   Kunishima, Tomoyuki ^f   Sato, Akira ^g   Nozato, Toshihiro ^h   Miyake, Shogo ⁱ   Takeyama, Youichi ^j   Morino, Yoshihiro ^k   Yamauchi, Takao ^l   Muramatsu, Toshiya ^m   Hibi, Kiyoshi ⁿ   Terashima, Mitsuyasu ^o   Michishita, Ichiro ^a  

^a Yokohama Sakae Kyosai Hospital   (Japan)

^b Tsurumi Nishiguchi Hospital   (Japan)

^c Yokohama Seamen's Insurance Hospital   (Japan)

^d Kanagawa Prefectural Cardiovascular and Respiratory Diseases Center Hospital   (Japan)

^e Hiratsuka Kyosai Hospital   (Japan)

^f TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g YOKOSUKA KYOSAI HOSPITAL   (Japan)

^h NATIONAL HOSPITAL ORGANIZATION   (Japan)

ⁱ Ebina General Hospital   (Japan)

^j SHOWA UNIVERSITY   (Japan)

^k TOKAI UNIVERSITY   (Japan)

^l TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^m SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

ⁿ YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^o Cardiovascular Imaging Center   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; PITAVASTATIN; PRAVASTATIN;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; TREATMENT DURATION; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, STABLE; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; JAPAN; LIPIDS; MALE; PLAQUE, ATHEROSCLEROTIC; PRAVASTATIN; QUINOLINES; REGRESSION ANALYSIS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84875228785     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.12.008     Document Type: Article

References (24)

1. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen, B.G. Brown, P. Ganz, R.A. Vogel, T. Crowe, G. Howard, C.J. Cooper, B. Brodie, C.L. Grines, A.N. DeMaria REVERSAL Investigators Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial JAMA 291 2004 1071 1080
2. S.E. Nissen, S.J. Nicholls, I. Sipahi, P. Libby, J.S. Raichlen, C.M. Ballantyne, J. Davignon, R. Erbel, J.C. Fruchart, J.C. Tardif, P. Schoenhagen, T. Crowe, V. Cain, K. Wolski, M. Goormastic, E.M. Tuzcu ASTEROID Investigators Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565
3. S. Okazaki, T. Yokoyama, K. Miyauchi, K. Shimada, T. Kurata, H. Sato, and H. Daida Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study Circulation 110 2004 1061 1068
4. T. Hiro, T. Kimura, T. Morimoto, K. Miyauchi, Y. Nakagawa, M. Yamagishi, Y. Ozaki, K. Kimura, S. Saito, T. Yamaguchi, H. Daida, M. Matsuzaki JAPAN-ACS Investigators Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study) J Am Coll Cardiol 54 2009 293 302
5. C.H. MacPhee, K.E. Moores, H.F. Boyd, D. Dhanak, R.J. Ife, C.A. Leach, D.S. Leake, K.J. Milliner, R.A. Patterson, K.E. Suckling, D.G. Tew, and D.M. Hickey Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor Biochem J 338 1999 479 487
6. E.H. Yang, J.P. McConnell, R.J. Lennon, G.W. Barsness, G. Pumper, S.J. Hartman, C.S. Rihal, L.O. Lerman, and A. Lerman Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans Arterioscler Thromb Vasc Biol 26 2006 106 111
7. C.J. Packard, D.S. O'Reilly, M.J. Caslake, A.D. McMahon, I. Ford, J. Cooney, C.H. Macphee, K.E. Suckling, M. Krishna, F.E. Wilkinson, A. Rumley, and G.D. Lowe Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease: West of Scotland Coronary Prevention Study Group N Engl J Med 343 2000 1148 1155
8. C.M. Ballantyne, R.C. Hoogeveen, H. Bang, J. Coresh, A.R. Folsom, G. Heiss, and A.R. Sharrett Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study Circulation 109 2004 837 842
9. L.B. Daniels, G.A. Laughlin, M.J. Sarno, R. Bettencourt, R.L. Wolfert, and E. Barrett-Connor Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study J Am Coll Cardiol 51 2008 913 919
10. T. Dohi, K. Miyauchi, S. Okazaki, T. Yokoyama, R. Ohkawa, K. Nakamura, N. Yanagisawa, S. Tsuboi, M. Ogita, K. Yokoyama, T. Kurata, Y. Yatomi, and H. Daida Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome Atherosclerosis 219 2011 907 912
11. T. Nozue, S. Yamamoto, S. Tohyama, S. Umezawa, T. Kunishima, A. Sato, S. Miyake, Y. Takeyama, Y. Morino, T. Yamauchi, T. Muramatsu, K. Hibi, T. Sozu, and I. Michishita Statin Treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis Am Heart J 163 2012 191 199
12. T. Nozue, S. Yamamoto, S. Tohyama, S. Umezawa, T. Kunishima, A. Sato, S. Miyake, Y. Takeyama, Y. Morino, T. Yamauchi, T. Muramatsu, K. Hibi, T. Sozu, I. Michishita Kanagawa PTCA Conference Study Group Treatment with statin on atheroma regression evaluated by intravascular ultrasound with virtual histology (TRUTH study): rationale and design Circ J 73 2009 352 355
13. H.M. García-García, G.S. Mintz, A. Lerman, D.G. Vince, M.P. Margolis, G.A. van Es, M.A. Morel, A. Nair, R. Virmani, A.P. Burke, G.W. Stone, and P.W. Serruys Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting EuroIntervention 5 2009 177 189
14. G.S. Mintz, H.M. Garcia-Garcia, S.J. Nicholls, N.J. Weissman, N. Bruining, T. Crowe, J.C. Tardif, and P.W. Serruys Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies EuroIntervention 6 2011 1123 1130
15. G.S. Mintz, S.E. Nissen, W.D. Anderson, S.R. Bailey, R. Erbel, P.J. Fitzgerald, F.J. Pinto, K. Rosenfield, R.J. Siegel, E.M. Tuzcu, and P.G. Yock American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS): a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol 37 2001 1478 1492
16. N. Leitinger, A.D. Watson, S.Y. Hama, B. Ivandic, J.H. Qiao, J. Huber, K.F. Faull, D.S. Grass, M. Navab, A.M. Fogelman, F.C. de Beer, A.J. Lusis, and J.A. Berliner Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids Arterioscler Thromb Vasc Biol 19 1999 1291 1298
17. L.S. Elinder, A. Dumitrescu, P. Larsson, U. Hedin, J. Frostegård, and H.E. Claesson Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall Arterioscler Thromb Vasc Biol 17 1997 2257 2263
18. E.J. Schaefer, J.R. McNamara, B.F. Asztalos, T. Tayler, J.A. Daly, J.L. Gleason, L.J. Seman, A. Ferrari, and J.J. Rubenstein Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects Am J Cardiol 95 2005 1025 1032
19. M.A. Albert, R.J. Glynn, R.L. Wolfert, and P.M. Ridker The effect of statin therapy on lipoprotein associated phospholipase A2 levels Atherosclerosis 182 2005 193 198
20. V. Tsimihodimos, S.A. Karabina, A.P. Tambaki, E. Bairaktari, J.A. Goudevenos, M.J. Chapman, M. Elisaf, and A.D. Tselepis Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB Arterioscler Thromb Vasc Biol 22 2001 306 311
21. J. Qian, A. Maehara, G.S. Mintz, M.P. Margolis, S. Biro, G.W. Stone, and M.B. Leon Relation between individual plaque components and overall plaque burden in the prospective, multicenter virtual histology intravascular ultrasound registry Am J Cardiol 104 2009 501 506
22. T. Nozue, S. Yamamoto, S. Tohyama, K. Fukui, S. Umezawa, Y. Onishi, T. Kunishima, A. Sato, T. Nozato, S. Miyake, Y. Takeyama, Y. Morino, T. Yamauchi, T. Muramatsu, K. Hibi, M. Terashima, I. Michishita TRUTH Investigators Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the TRUTH study) Am J Cardiol 109 2012 1247 1253
23. T. Kovarnik, G.S. Mintz, H. Skalicka, A. Kral, J. Horak, R. Skulec, J. Uhrova, P. Martasek, R.W. Downe, A. Wahle, M. Sonka, V. Mrazek, M. Aschermann, and A. Linhart Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: HEAVEN study Circ J 76 2012 176 183
24. S.W. Lee, W.K. Hau, S.L. Kong, K.K. Chan, P.H. Chan, S.C. Lam, F.C. Tam, M.K. Wong, C.W. Chan, Y.M. Lam, H.F. Tse, and R.H. Chan Virtual histology findings and effects of varying doses of atorvastatin on coronary plaque volume and composition in statin-naive patients Circ J 76 2012 2662 2672